Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

7359dba7-e1da-4eb4-8765-58da6178899b

Sarepta’s investigational gene therapy shows strength in limb-girdle muscular dystrophy Type 2E

October 7, 2019 Research and Development, Sales and Marketing muscular dystrophy, pharma, sarepta

Sarepta Therapeutics has revealed positive new data for its investigational gene therapy SRP-9003 in the treatment of limb-girdle muscular dystrophy …
News
jj_sign_on_wall

Johnson & Johnson commits $500m to end HIV and TB Epidemics

October 4, 2019 Medical Communications, Research and Development

Johnson & Johnson have announced it has committed to ensuring more than $500 million is dedicated to R&D delivery programs …
News
shutterstock_212432119

Arbutus Biopharma moves to terminate development of chronic hepatitis B therapy after trial failure

October 4, 2019 Medical Communications, Research and Development Arbutus Biopharma, hepatitis B, pharma

Arbutus Biopharma has announced its decision to terminate the development of its oral capsid inhibitor, known as AB-506, in the …
News
novartis_side_building

Novartis selects Microsoft for AI drug development

October 3, 2019 Research and Development

Novartis has begun an alliance with Microsoft to leverage the latter’s artificial intelligence (AI) technology for the discovery, development and …
News

Novartis plans FDA approval as it hits endpoint for Consentyx in axial spondyloarthritis

October 3, 2019 Research and Development

Novartis has announced positive data from its PREVENT trial, which evaluated the safety and efficacy of Cosentyx (secukinumab) for patients …
News
sandrock-al-e1548286908776

Biogen announces leadership updates

October 2, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biogen have announced updates to it senior leadership team with Alfred Sandrock being named Executive Vice President of Research and …
Appointment
opdivo_1_1

BMS’ Opdivo bests chemotherapy in oesophageal squamous cell carcinoma

October 2, 2019 Research and Development Bristol-Myers Squibb, Cancer, ESMO 2019, opdivo, pharma

Bristol-Myers Squibb took the opportunity at the European Society for Medical Oncology (ESMO) 2019 Annual Congress to present new Phase …
News
invokana

FDA grants Johnson & Johnson’s Invokana new kidney disease approval

October 2, 2019 Research and Development

Johnson & Johnson’s Invokana (canaglifolozin) has become the only drug in the SGLT2 inhibitor class to be approved by the …
News

AstraZeneca strikes global commercial rights deal for $243m

October 2, 2019 Research and Development

Cambridge-headquartered AstraZeneca have agreed to sell certain global commercial rights for its Losec brand, in a deal that is worth …
News
gsk_boronia_australia

GSK’s Zejula slows disease progression in a range of ovarian cancers

October 2, 2019 Research and Development Cancer, ESMO 2019, GSK, Zejula, ovarian cancer, pharma

At the 2019 European Society for Medical Oncology (ESMO) congress, GlaxoSmithKline unveiled new Phase 3 data on Zejula (niraparib) for …
News
jj_sign_on_wall

Johnson & Johnson settle opioid lawsuits in Ohio for $20m

October 2, 2019 Research and Development

Johnson & Johnson have agreed to settle opioid litigation with two Ohio counties for roughly $20.4 million in a deal …
News
dave_peacock

MSD announce David Peacock as new Managing Director in UK and Ireland

October 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

MSD have announced that David Peacock will become Managing Director in the UK and Ireland, succeeding former director Louise Houson, …
Appointment

Sanofi’s Jevtana doubles progression-free survival in metastatic castration-resistant prostate cancer

October 1, 2019 Manufacturing and Production, Research and Development ESMO 2019, Jevtana, Sanofi, pharma, prostate cancer

Sanofi was present at the 2019 European Society of Medical Oncology (ESMO) Congress in Barcelona this year to reveal new …
News

Chris Whitty begins role as England’s Chief Medical Officer

October 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

London consultant and public health professor, Chris Whitty, has begun his role as England’s Chief Medical Officer, taking over from …
Appointment
roche__tree

Roche’s Tecentriq plus chemo shows promise in first-line, advanced bladder cancer

October 1, 2019 Manufacturing and Production, Research and Development Cancer, ESMO 2019, Roche, breast cancer, pharma, tecentriq

Roche has revealed data from an interim analysis of its immunotherapy Tecentriq (atezolizumab) at the 2019 European Society for Medical …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025